Lactoferrin presence in placenta and amniotic fluid is involved in the prevention of pregnancy complications thanks to its anti-infective and anti-inflammatory properties and thus, it is conceivable that it could play a role also in preventing SARS-CoV-2 vertical transmission and COVID-19 pregnancy negative outcomes [114,115,118]. This evidence concerns the gene LTF and COVID-19.